Health Condition 1: null- all patients undergoing gynaecological operative procedures
Conditions
Interventions
Intervention1: bupivacaine: intraperitoneal and skin infiltration with 0.125 % Bupivacaine, 30 ml at the end of laparoscopic operative gynaecological procedure and recording pain scores in post operat
Sponsors
Armed Forces Medical College
Eligibility
Inclusion criteria
Inclusion criteria: ASA status I & II All cases of Operative laparoscopic gynaecological surgeries
Exclusion criteria
Exclusion criteria: Laparoscopic Gynaecological Oncology surgeries history of opiod use/ alcohol abuse in last 24 hours prior to study Weight history of allergy to the drug in study Chronic Pain Syndrome
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To evaluate the efficacy of port site and intraperitoneal Bupivacaine in reducing post operative pain by comparing VAS scores between intervention and control armTimepoint: 2 hour, 4hours and 8 hours post operatively | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To evaluate the safety and note the side effects if any of port site and intraperitoneal Bupivacaine used for reducing post operative pain 2.To compare the need for rescue analgesia between the intervention and control armTimepoint: 2 hour, 4hours and 8 hours post operatively | — |
Countries
India
Contacts
Public ContactSqn Ldr Isha Bansal
Armed Forces Medical College
Outcome results
None listed